On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency

Here we present the synthesis and evaluation of antibody-drug conjugates (ADCs), for which antibody and drug are non-covalently connected using complementary DNA linkers. These ADCs are composed of trastuzumab, an antibody targeting HER2 receptors overexpressed on breast cancer cells, and monomethyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Dovgan, Igor, Ehkirch, Anthony, Lehot, Victor, Kuhn, Isabelle, Koniev, Oleksandr, Kolodych, Sergii, Hentz, Alexandre, Ripoll, Manon, Ursuegui, Sylvain, Nothisen, Marc, Cianférani, Sarah, Wagner, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203131/
https://www.ncbi.nlm.nih.gov/pubmed/32376903
http://dx.doi.org/10.1038/s41598-020-64518-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203131/
https://www.ncbi.nlm.nih.gov/pubmed/32376903
http://dx.doi.org/10.1038/s41598-020-64518-y

Ejemplares similares